Skip to main content
. Author manuscript; available in PMC: 2012 Aug 12.
Published in final edited form as: Neuroscience. 2007 May 23;147(2):546–560. doi: 10.1016/j.neuroscience.2007.02.065

Table 1.

Experimental Groups

Exp. groups Post-injury time Cell/medium inj. Cell density/No. of injections Assessment of Motor function (BBB score) Motor Evoked Potentials Post- Graft survival Histology/Stereo. Quant.
Study I
A1 (n=4) 3 days 30, 000/10 − − 7–14 days +/−
A2 (n=5) 7 days 30, 000/10 − − 7–14 days +/−
A3 (n=12) 21 days 30, 000/10 + − 1–8 weeks +/−
A4 (n=7) 21 days Medium/10 + − 8 weeks +/−
Study II
B1 (n=4) 21 days 5, 000/10 − − 2–7 weeks +/−
B2 (n=4) 21 days 10, 000/10 − − 2–7 weeks +/+
B3 (n=4) 21 days 30, 000/10 − − 2–7 weeks +/+
B4 (n=4) 21 days 50, 000/10 − − 2–7 weeks +/−
Study III
C1 (n=13) 21 days 10, 000/25–30 + − 3 months +/−
C2 (n=6) 21 days Medium/25–30 + + 3 months +/−